Episode Details
Back to Episodes
Episode 322 ASCO24: The role of ctDNA in the TheraP trial (LuPSMA vs cabazitaxel in CRPC)
Season 3
Published 2 years, 4 months ago
Description
Alex Wyatt describes the predictive resistance of ctDNA fraction at baseline in predicting outcome.